1. Home
  2. NTIC vs GNTA Comparison

NTIC vs GNTA Comparison

Compare NTIC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$8.02

Market Cap

81.9M

Sector

Industrials

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.49

Market Cap

69.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
GNTA
Founded
1970
2014
Country
United States
Italy
Employees
N/A
9
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.9M
69.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NTIC
GNTA
Price
$8.02
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1K
62.6K
Earning Date
04-09-2026
03-24-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$84,234,474.00
N/A
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.16
$0.55
52 Week High
$10.03
$10.00

Technical Indicators

Market Signals
Indicator
NTIC
GNTA
Relative Strength Index (RSI) 47.45 48.42
Support Level $7.85 $1.30
Resistance Level $8.27 $1.70
Average True Range (ATR) 0.13 0.14
MACD -0.02 -0.01
Stochastic Oscillator 39.59 60.42

Price Performance

Historical Comparison
NTIC
GNTA

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: